Triptodur Kit
Product Images NDC 24338-150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Triptodur (NDC 24338-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Triptodur 01)

FDA Label Image

Image (Triptodur 02)

FDA Label Image

Image (Triptodur 03)

FDA Label Image

Image (Triptodur 04)

FDA Label Image

Image (Triptodur 05)

FDA Label Image

Image (Triptodur 06)

FDA Label Image

Image (Triptodur 07)

FDA Label Image

Image (Triptodur 08)

FDA Label Image

Image (Triptodur 09)

FDA Label Image

Image (Triptodur 10)

FDA Label Image

Chemical Structure (Triptodur 11)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Trlptodur is an injectable medication used for extended-release that contains triptorelin. It is administered intramuscularly as a single dose once every 24 weeks. The kit comes with one single-dose vial, one pre-filled syringe of diluent, and two thin-walled needles. This should be reconstituted with accompanying diluent before use. It should be stored at a controlled room temperature between 20 to 25°C, and it is not recommended to be frozen. The accompanying medication guide should be dispensed to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.